# Effect of Dexmedetomidine and Propofol on Regional Cerebral Tissue Oxygen Saturation

> **NCT03817112** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 50 (actual)

## Conditions studied

- Regional Cerebral Tissue Oxygen Saturation

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride 0.1 MG/ML
- **DRUG:** Propofol 10 MG/ML

## Key facts

- **NCT ID:** NCT03817112
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2018-09-30
- **Final completion:** 2019-01-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817112, "Effect of Dexmedetomidine and Propofol on Regional Cerebral Tissue Oxygen Saturation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03817112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
